TELOMIR PHARMACEUTICALS, INC. - Florida Company Profile
Share on:
Share on:
| Entity Name: | TELOMIR PHARMACEUTICALS, INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: |
Domestic Profit
TELOMIR PHARMACEUTICALS, INC. is structured as a Domestic Profit Corporation, which, in Florida signifies a Profit Corporation (also known as a C-Corporation). This business structure is recognized as a separate legal entity from its owners. This offers shareholders the benefit of limited liability protection, safeguarding their personal assets from the corporation's debts and obligations, and facilitates raising capital through the issuance of stock. In Florida, Domestic Profit Corporations are governed by Title XXXVI, Chapter 607, Florida Statutes – Florida Business Corporation Act. |
| Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
| Date Filed: | 26 Aug 2021 (4 years ago) |
| Last Event: | AMENDED AND RESTATED ARTICLES |
| Event Date Filed: | 11 Dec 2023 (2 years ago) |
| Document Number: | P21000076653 |
| FEI/EIN Number |
87-2606031
Federal Employer Identification (FEI) Number assigned by the IRS. |
| Address: | 100 SE 2nd St., Suite 200 #1009, Miami, FL, 33131, US |
| Mail Address: | 100 SE 2nd St., Suite 200 #1009, Miami, FL, 33131, US |
| ZIP code: | 33131 |
| County: | Miami-Dade |
| Place of Formation: | FLORIDA |
| Name | Role | Address |
|---|---|---|
| Aminov Erez | Chief Executive Officer | 900 W. Platt St., Tampa, FL, 33606 |
| Yanez Michelle | Chief Financial Officer | 900 W. Platt St., Tampa, FL, 33606 |
| Eagle Craig Dr. | Director | 900 W. Platt St., Tampa, FL, 33606 |
| Panhans Austin | Agent | 900 W Platt St, Tampa, FL, 33606 |
| MacPherson Ned | Director | 100 SE 2nd St., Miami, FL, 33131 |
| Whalen Matthew | Director | 100 SE 2nd St., Miami, FL, 33131 |
| De Giudice Matthew | Director | 100 SE 2nd St., Miami, FL, 33131 |
A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly
traded on U.S. stock exchanges, File reports with the SEC.
Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must
comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR
database.
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| CHANGE OF PRINCIPAL ADDRESS | 2025-02-10 | 100 SE 2nd St., Suite 200 #1009, Miami, FL 33131 | - |
| CHANGE OF MAILING ADDRESS | 2025-02-10 | 100 SE 2nd St., Suite 200 #1009, Miami, FL 33131 | - |
| REGISTERED AGENT NAME CHANGED | 2024-08-21 | Panhans, Austin | - |
| CHANGE OF PRINCIPAL ADDRESS | 2024-04-09 | 900 W. Platt St., Suite 200, Tampa, FL 33606 | - |
| AMENDED AND RESTATEDARTICLES | 2023-12-11 | - | - |
| REGISTERED AGENT ADDRESS CHANGED | 2023-04-11 | 900 W Platt St, Suite 200, Tampa, FL 33606 | - |
| CHANGE OF MAILING ADDRESS | 2022-10-17 | 900 W. Platt St., Suite 200, Tampa, FL 33606 | - |
| AMENDED AND RESTATEDCERT/NAME CHANGE | 2022-10-10 | TELOMIR PHARMACEUTICALS, INC. | - |
| Name | Date |
|---|---|
| ANNUAL REPORT | 2025-02-10 |
| AMENDED ANNUAL REPORT | 2024-08-21 |
| ANNUAL REPORT | 2024-04-09 |
| Amended and Restated Articles | 2023-12-11 |
| ANNUAL REPORT | 2023-04-11 |
| Amended/Restated Cert & NC | 2022-10-10 |
| ANNUAL REPORT | 2022-04-21 |
| Domestic Profit | 2021-08-26 |
This company hasn't received any reviews.
Date of last update: 02 Jun 2025
Sources: Florida Department of State